|05-16-2019 06:53 PM CET - Health & Medicine||
High Content Screening Market Estimated to Rise Profitably with CAGR of 9.8% during 2019 – 2024 | Global Key Vendors - GE Healthcare, Danaher, Perkinelmer, Thermo Fisher Scientific, Bio-Rad Lab, Yokogawa Electric
Press release from: ProgMark
Global High Content Screening Market research report 2019 - 2024 provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.
Overview of the Global High Content Screening Market:
The report spread across 110 pages is an overview of the Global High Content Screening Market. These report study based on the High Content Screening Market. It is a complete overview of the market, covering various aspects prevailing market landscape. It accumulates comprehensive information and research methodologies.
The Global High Content Screening Market is Valued at USD 600 Million in 2018 and will reach USD 1.05 Billion by the end of 2024, registering a growth rate of 9.8%.
Get a Sample Copy of this Report @ marketprognosis.com/sample-request/19725 .
Under the conventional method of toxicity studies, large libraries are screened in search of potential drug candidates. This method is expensive, resource- and time-consuming, and has a low success rate. Consequently, High Content Screening (HCS) solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in-vitro toxicity testing by reducing the time and cost. The need for cost containment in pharmaceutical R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the High Content Screening (HCS) Market.
On the basis of Product Type segment, the High Content Screening (HCS) Market is further segmented into instruments, consumables, software, services, and accessories. The market for HCS software is expected to increase with the highest CAGR between 2019 and 2024. Among all high content screening products, the instrument segment occupies the largest share of the market. The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.
Geographically, the High Content Screening Market in Asia-Pacific is expected to increase at the highest CAGR during the forecast period. Factors, such as increasing drug discovery research, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure are driving the growth of the High Content Screening Market in this region.
This comprehensive High Content Screening Market research report 2019 – 2024 includes a brief on these trends that can help the businesses operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market size, industry share, growth, key segments, CAGR and key drivers.
Major Key Players:
1 GE Healthcare
2 Danaher Corporation
3 Perkinelmer Inc.
4 Thermo Fisher Scientific Inc.
5 Becton, Dickinson and Company
6 Biotek Instruments Inc.
7 Bio-Rad Laboratories Inc.
8 Yokogawa Electric Corporation
9 Merck Millipore and More……………..
Purchase this report online with 110 Pages, Top Key Players Analysis and List of Tables & Figure @ marketprognosis.com/buyReport/19725 .
Table of Contents:
2 Global High Content Screening Market Research Methodology
3 Executive Summary
4 Global High Content Screening Market Dynamics
5 Global High Content Screening Market Segmentation
6 Competitive Landscape
7 Global High Content Screening Market Opportunities and Future Trends
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.
ProgMark Pvt. Ltd.
Thane – 421501
+1 973 241 5193
This release was published on openPR.
News-ID: 1742504 • Views: 316More releases